The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018
| Autor: | Deborah Holtzman, Alice Asher, Sarah Schillie |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Hepatitis C virus Hepacivirus medicine.disease_cause 03 medical and health sciences Health problems Age Distribution 0302 clinical medicine Risk Factors Epidemiology Prevalence Humans Medicine Needle Sharing 030212 general & internal medicine Sex Distribution Substance Abuse Intravenous Research & Analysis 030505 public health business.industry Incidence Public Health Environmental and Occupational Health Opioid-Related Disorders Hepatitis C Virology United States Socioeconomic Factors Opinions Ideas & Practice 0305 other medical science business |
| Zdroj: | Am J Public Health |
| ISSN: | 1541-0048 0090-0036 |
| Popis: | Hepatitis C virus (HCV) infection remains an important cause of morbidity and mortality throughout the world, leading to serious health problems among those who are chronically infected. Since 1992, the Centers for Disease Control and Prevention has been collecting data on the incidence of HCV infection in the United States. In 2018, more than 50 000 individuals were estimated to have acute HCV infection. The most recently reported data on the prevalence of infection indicate that approximately 2.4 million people are living with hepatitis C in the United States. Transmission of HCV occurs predominantly through sharing contaminated equipment for injecting drugs. Two major events have had a significant impact on the incidence and prevalence of hepatitis C in the past few decades: the US opioid crisis and the discovery of curative treatments for HCV infection. To better understand the impact of these events, we examine reported trends in the incidence and prevalence of infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|